| 2018-01-17 | Sale | MacroGenics, Inc. MGNX | Sr VP, Clinical Dev. & CMO | 5,048 0.0138% | $20.00 | $100,960 | +8.77% | |
| 2018-01-16 | Sale | MacroGenics, Inc. MGNX | Sr VP, Clinical Dev. & CMO | 2,476 0.0016% | $4.70 | $11,637 | +9.15% | |
| 2017-11-21 | Sale | MacroGenics, Inc. MGNX | Sr VP, Clinical Dev. & CMO | 10,000 0.0171% | $12.35 | $123,500 | +7.79% | |
| 2017-10-25 | Sale | MacroGenics, Inc. MGNX | Sr VP, Clinical Dev. & CMO | 20,000 0.036% | $12.35 | $247,000 | +13.63% | |
| 2017-06-05 | Sale | MacroGenics, Inc. MGNX | Sr VP, Clinical Dev. & CMO | 10,000 0.0172% | $12.35 | $123,500 | -4.11% | |
| 2017-04-19 | Sale | MacroGenics, Inc. MGNX | Sr VP, Clinical Dev. & CMO | 30,000 0.0514% | $12.35 | $370,500 | -5.44% | |
| 2016-10-03 | Sale | MacroGenics, Inc. MGNX | Sr VP, Clinical Dev. & CMO | 10,000 0.0284% | $29.34 | $293,400 | -35.7% | |
| 2016-08-01 | Sale | MacroGenics, Inc. MGNX | Sr VP Clinical Dev & CMO | 40,000 0.0661% | $17.74 | $709,600 | -35.78% | |
| 2016-07-01 | Sale | MacroGenics, Inc. MGNX | Sr VP Clinical Dev & CMO | 10,000 0.0169% | $15.96 | $159,600 | -23.28% | |
| 2016-01-04 | Sale | MacroGenics, Inc. MGNX | Sr VP, Clinical | 20,000 0.0338% | $17.17 | $343,400 | -16.7% | |
| 2015-10-01 | Sale | MacroGenics, Inc. MGNX | Sr VP, Clinical | 10,000 0.0322% | $21.11 | $211,100 | +27.34% | |
| 2015-08-03 | Sale | MacroGenics, Inc. MGNX | Sr VP, Clinical | 20,000 0.059% | $37.15 | $743,000 | -31.54% | |
| 2015-07-01 | Sale | MacroGenics, Inc. MGNX | Sr VP, Clinical | 10,000 0.0178% | $20.93 | $209,250 | -26.32% | |
| 2015-04-01 | Sale | MacroGenics, Inc. MGNX | Sr VP, Clinical | 10,000 0.0187% | $17.78 | $177,800 | -2.61% | |
| 2015-02-02 | Sale | MacroGenics, Inc. MGNX | Sr VP, Clinical | 10,000 0.0192% | $17.87 | $178,700 | +1.21% | |
| 2014-10-01 | Sale | MacroGenics, Inc. MGNX | Sr V.P., Clinical | 10,000 0.0233% | $12.59 | $125,900 | +62.24% | |
| 2014-08-18 | Sale | MacroGenics, Inc. MGNX | Senior VP, Clinical Dev. | 10,000 0.0217% | $12.61 | $126,100 | +53.4% |